WCM
TEVA icon

Winthrop Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Winthrop Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Hold
6,000
– – 0.05% 121
2026
Q1 		$181K Hold
6,000
– – 0.05% 125
2025
Q4 		$187K Hold
6,000
– – 0.04% 131
2025
Q3 		$121K Hold
6,000
– – 0.03% 137
2025
Q2 		$101K Hold
6,000
– – 0.03% 152
2025
Q1 		$92K Hold
6,000
– – 0.03% 141
2024
Q4 		$134K Hold
6,000
– – 0.04% 137
2024
Q3 		$108K Buy
+6,000
New +$105K 0.05% 71

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Winthrop Capital Management's TEVA Position: Q2 2026 in Review

Winthrop Capital Management held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 6,000 shares worth $203K. The position accounts for 0.05% of the portfolio, ranked #121.

Winthrop Capital Management first reported a position in TEVA in Q3 2024 and has held it in 8 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Winthrop Capital Management held 6,000 shares of Teva Pharmaceuticals worth $203K as of Q2 2026.
  • Winthrop Capital Management left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up 0.05% of Winthrop Capital Management's portfolio in Q2 2026, its #121 holding.
  • Winthrop Capital Management first reported a position in Teva Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Winthrop Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.